Refine by
Biopsy Sampling Articles & Analysis
19 news found
"Our See.d instrument prepares high-quality samples, ensuring precise measurement of both cellular and cell-free tumor markers in blood. ...
The two companies collaborated with precision medicine clinical research organization (CRO) Precision for Medicine, which contributes its state-of-the-art, CAP-accredited, CLIA-certified laboratory services to Boundless Bio’s POTENTIATE Phase 1/2 clinical trial by successfully validating a proprietary workflow to process patient samples. It is well established that ...
Combining 3-D ultrasound and MRI technology can accurately map biopsy samples. Technological advancements in imaging mean swift and accurate diagnoses of PC with less ambiguity than previously encountered. ...
The group, which also included UW-Madison professors Shigeki Miyamoto and David Beebe, and postdoctoral fellow Edmond Young, would receive large numbers of patient samples from hospitals containing cancer cells so that the researchers could analyze them, Pak says. One major challenge they faced was that some of the samples, which were derived from patient ...
We report that opioids from the inflamed colon activate δ-opioid receptors (DOPr) in endosomes of nociceptors. Biopsy samples of inflamed colonic mucosa from patients and mice with colitis released opioids that activated DOPr on nociceptors to cause a sustained decrease in excitability. ...
“Promega has demonstrated exceptional quality of results from samples processed with their proven reagents on Maxwell systems, which have been adopted globally for liquid biopsies. ...
SAGA Diagnostics AB is seeking a talented and highly motivated Bioinformatics Scientist with strong interest in advancing our mission to revolutionize cancer diagnostics through proprietary ultrasensitive technologies that measure circulating tumor DNA (ctDNA) in minimally-invasive “liquid biopsies” such as a simple blood sample. The candidate will ...
A new biopsy sheath developed by Raleigh med tech startup UVision360 is ready to hit the market after landing federal approval this week. ...
Cleared by the FDA, VelacurTM is a handheld, point of care ultrasound solution that quantifies liver stiffness using technology similar to MRI elastography combined with 3D tissue sampling. Unlike biopsy and MRI, the procedure is non-invasive, comfortable and convenient. ...
THE TWO BELGIAN COMPANIES WILL WORK TOWARDS A BETTER UNDERSTANDING OF NON-SMALL CELL LUNG CANCER BIOLOGY AND CHARACTERIZATION OF THE TUMORS USING AI TECHNOLOGY Radiomics and OncoDNA are pleased to announce that they have entered into a strategic agreement, combining Radiomics’ next-generation AI-based technology to extract quantitative information embedded in medical images with ...
With the Raman probe, laser illumination of the tumour provides a rainbow spectrum that contains detailed information about a sample’s chemical structure. That information helps surgeons identify previously undetectable cancer cells. ...
SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, has entered into an assay development agreement with the global, science-led biopharmaceutical company AstraZeneca (LSE/STO/Nasdaq: AZN). SAGA Diagnostics will in the course of this agreement develop unique ...
Pierre Sonigo, Chief Scientific Officer of the Sebia Group, said "Metafora's technology achieves the equivalent of a PET-Scan, the reference technology for cancer imaging, on "liquid biopsies", i.e., from a simple blood sample. The resolution of this analysis, which is based on flow cytometry, is the highest achievable since the sample is ...
The LUMINELLE DTx System is an endoscopic platform assisting both male/female procedures, bringing operating room capabilities affordably to physician offices so bladder and uterine tissue samples can be obtained easily with visualization. "The FDA approval of our LUMINELLE Bx Sheath not only marks a major milestone for UVision360 but is also a game changer when it comes to the ...
SAGA Diagnostics AB (“SAGA”), a cancer liquid biopsy and genomic testing company, today announced that it has raised SEK 106 million (€10.5 million) in a Series A2 financing from both existing and new investors. ...
Trial had 90% statistical power (two-sided 0.05 alpha-level) for the evaluation of the primary endpoint Results are based on the demonstration of having no evidence of HSIL associated with HPV-16 and/or HPV-18 from cervical biopsy samples and non-detectability of HPV-16 and/or HPV-18 using the cobas® HPV test from ThinPrep samples, at ...
The use of this technology allows a novel way to obtain an office-based endometrial biopsy, a very common tissue-sampling procedure performed in women’s health offices worldwide. The ETS is the third product using the frictionless CrossGlide™ technology to receive marketing authorization and will be made available for use in endometrial ...
Nevertheless, large-scale gene expression profiling from biopsy samples is not currently feasible,” said Thomas Stavros, MD, Chief Medical Officer of Seno Medical. ...
The EMI-137 agent can help doctors more easily identify these suspicious lesions, take a sample (biopsy) or remove the lesion completely. Colorectal cancer is the second most common cause of cancer in women and the third most common in men, and is a major cause of death. ...